Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 8, 2007, Pages 1322-1327

  Saigusa, Susumu ^a   Ichikura, Takashi ^a   Tsujimoto, Hironori ^a   Sugasawa, Hidekazu ^a   Majima, Takashi ^a   Kawarabayashi, Nobuaki ^a   Chochi, Kentaro ^a   Ono, Satoshi ^a   Kinoshita, Manabu ^a   Seki, Shuhji ^a   Ogawa, Kazuyuki ^b   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b BML   (Japan)

Author keywords

Cellular immunity; Gastric cancer; Granule exocytosis; Granulysin; Prognosis

Indexed keywords

GRANULYSIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MALE; PERITONEUM METASTASIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH CARCINOMA;

EID: 34547692469     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04796.x     Document Type: Article

References (28)

1. Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol. 1990 8 : 279 302.
2. Jenne DE, Tschopp J. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol. Rev. 1988 103 : 53 71.
3. Clayberger C, Krensky AM. Granulysin. Curr. Opin. Immunol. 2003 15 : 560 5.
4. Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 1997 158 : 2680 8.
5. Obata-Onai A, Hashimoto S, Onai N et al. Comprehensive gene expression analysis of human NK cells and CD8 (+) T lymphocytes. Int. Immunol. 2002 14 : 1085 98.
6. Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J. Immunol. 1998 161 : 1758 64.
7. Wang Z, Choice E, Kaspar A et al. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J. Immunol. 2000 165 : 1486 90.
8. Ogawa K, Takamori Y, Suzuki K et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur. J. Immunol. 2003 33 : 1925 33.
9. Sobin LH, Fleming ID. TNM classification of malignant tumors, 5th edn. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997 80 : 1803 4.
10. Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM. Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J. Immunol. 2005 174 : 5243 8.
11. Sekiya M, Ohwada A, Katae M, Dambara T, Nagaoka I, Fukuchi Y. Adenovirus vector-mediated transfer of 9 kDa granulysin induces DNA fragmentation in HuD antigen-expressing small cell lung cancer murine model cells. Respirology 2002 7 : 29 35.
12. Sakai M, Ogawa K, Shiozaki A et al. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin. Exp. Immunol. 2004 136 : 114 9.
13. Anichini A, Vegetti C, Mortarini R. The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma. Cancer Immunol. Immunother. 2004 53 : 855 64.
14. Numata A, Minagawa T, Asano M, Nakane A, Katoh H, Tanabe T. Functional evaluation of tumor-infiltrating mononuclear cells. Detection of endogenous interferon-gamma and tumor necrosis factor-alpha in human colorectal adenocarcinomas. Cancer 1991 68 : 1937 43.
15. Kawabata T, Ichikura T, Majima T et al. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 2001 92 : 2050 5.
16. Moy PM, Holmes EC, Golub SH. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res. 1985 45 : 57 60.
17. Uchida A, Kariya Y, Okamoto N, Sugie K, Fujimoto T, Yagita M. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients. J. Natl. Cancer Inst. 1990 82 : 1697 701.
18. Sulitzeanu D. Immunosuppressive factors in human cancer. Adv. Cancer Res. 1993 60 : 247 67.
19. Kishi A, Takamori Y, Ogawa K et al. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer. Cancer Immunol. Immunother. 2002 50 : 604 14.
20. Chochi K, Ichikura T, Majima T et al. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer. Oncol. Rep. 2003 10 : 1443 8.
21. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996 77 : 1226 43.
22. Terabe M, Park JM, Berzofsky JA. Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol. Immunother. 2004 53 : 79 85.
23. Clark WH Jr, Elder DE, Guerry Dt et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl Cancer Inst. 1989 81 : 1893 904.
24. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996 77 : 1303 10.
25. Aebersold P, Hyatt C, Johnson S et al. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J. Natl Cancer Inst. 1991 83 : 932 7.
26. Finke JH, Rayman P, Alexander J et al. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Cancer Res. 1990 50 : 2363 70.
27. Curiel TJ, Coukos G, Zou L et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004 10 : 942 9.
28. Pages F, Berger A, Camus M et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 2005 353 : 2654 66.